PLEKHJ1
Pleckstrin homology domain-containing family J member 1
Also known as: FLJ10297, PKHJ1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NW61
- Gene
- PLEKHJ1
- Ensembl
- ENSG00000104886
- Chromosome
- 19
- Canonical length
- 149 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Predicted to be involved in endosome organization; receptor recycling; and retrograde transport, endosome to Golgi. Predicted to be located in Golgi apparatus; cytoplasmic vesicle; and cytosol. Predicted to be active in early endosome; recycling endosome; and trans-Golgi network. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
149 residues, UniProt reviewed canonical sequence.
>Q9NW61|PLEKHJ1
1 MRYNEKELQA LSRQPAEMAA ELGMRGPKKG SVLKRRLVKL VVNFLFYFRT DEAEPVGALL
61 LERCRVVREE PGTFSISFIE DPERKYHFEC SSEEQCQEWM EALRRASYEF MRRSLIFYRN
121 EIRKVTGKDP LEQFGISEEA RFQLSGLQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLEKHJ1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 103 nTPM
Expression across tissuesHPA
Tissue
- colon: 103 nTPM
- duodenum: 99 nTPM
- kidney: 97 nTPM
- small intestine: 95 nTPM
- stomach: 93 nTPM
- pancreas: 90 nTPM
Single-cell type
- enterocytes: 319 nCPM
- colonocytes: 305 nCPM
- enteric transient amplifying cells: 247 nCPM
- paneth cells: 213 nCPM
- enteric stem cells: 209 nCPM
- parietal cells: 202 nCPM
Immune cell
- plasmacytoid DC: 159 nTPM
- naive B-cell: 144 nTPM
- eosinophil: 130 nTPM
- memory B-cell: 119 nTPM
- T-reg: 113 nTPM
- non-classical monocyte: 109 nTPM
Brain region
- thalamus: 45 nTPM
- pons: 40 nTPM
- midbrain: 37 nTPM
- amygdala: 36 nTPM
- medulla oblongata: 34 nTPM
- cerebral cortex: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0.07
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of PLEKHJ1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLEKHJ1 as an antibody target. Whether an autoantibody or antibody against PLEKHJ1 could matter depends on whether native PLEKHJ1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLEKHJ1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLEKHJ1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...